SF3B1 and myelodysplastic syndrome: Although the RS proportion in this patient exceeded 15%, SF3B1 testing was negative, and there was no significant dysplasia or increase in blasts in the bone marrow, thus not fulfilling the morphological or molecular diagnostic criteria for MDS-RS.